BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38519268)

  • 21. Survival after the diagnosis of de novo malignancy in liver transplant recipients.
    Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
    Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
    Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort.
    Lucidi C; Biolato M; Lai Q; Lattanzi B; Lenci I; Milana M; Lionetti R; Liguori A; Angelico M; Tisone G; Avolio AW; Agnes S; Rossi M; Grieco A; Merli M
    Ann Hepatol; 2021; 24():100309. PubMed ID: 33482364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
    Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
    Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society.
    Kasahara M; Umeshita K; Sakamoto S; Fukuda A; Furukawa H; Sakisaka S; Kobayashi E; Tanaka E; Inomata Y; Kawasaki S; Shimada M; Kokudo N; Egawa H; Ohdan H; Uemoto S;
    Am J Transplant; 2018 Mar; 18(3):659-668. PubMed ID: 28889651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living-donor liver transplantation for progressive familial intrahepatic cholestasis.
    Hori T; Egawa H; Miyagawa-Hayashino A; Yorifuji T; Yonekawa Y; Nguyen JH; Uemoto S
    World J Surg; 2011 Feb; 35(2):393-402. PubMed ID: 21125272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
    Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
    Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Impacts of Donor Types of Living vs. Deceased Donors: Predictors of One-Year Mortality in Patients with Liver Transplantation.
    Kim EJ; Lim S; Chu CW; Ryu JH; Yang K; Park YM; Choi BH; Lee TB; Lee SJ
    J Korean Med Sci; 2017 Aug; 32(8):1258-1262. PubMed ID: 28665060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.
    Sandal S; Almudevar A; Parajuli S; Bose A
    Clin Transplant; 2015 Dec; 29(12):1140-7. PubMed ID: 26383173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation.
    Yoshizumi T; Itoh S; Shimokawa M; Inokuchi S; Harada N; Takeishi K; Mano Y; Yoshiya S; Kurihara T; Nagao Y; Ikegami T; Soejima Y; Mori M
    J Hepatol; 2021 Feb; 74(2):372-379. PubMed ID: 32827564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and risk factors for infection after living donor liver transplantation.
    Abad CL; Lahr BD; Razonable RR
    Liver Transpl; 2017 Apr; 23(4):465-477. PubMed ID: 28176451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases.
    Hernandez-Alejandro R; Ruffolo LI; Sasaki K; Tomiyama K; Orloff MS; Pineda-Solis K; Nair A; Errigo J; Dokus MK; Cattral M; McGilvray ID; Ghanekar A; Gallinger S; Selzner N; Claasen MPAW; Burkes R; Hashimoto K; Fujiki M; Quintini C; Estfan BN; Kwon CHD; Menon KVN; Aucejo F; Sapisochin G
    JAMA Surg; 2022 Jun; 157(6):524-530. PubMed ID: 35353121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases.
    Iida T; Kaido T; Yagi S; Hori T; Uchida Y; Jobara K; Tanaka H; Sakamoto S; Kasahara M; Ogawa K; Ogura Y; Mori A; Uemoto S
    Clin Transplant; 2014 Sep; 28(9):1025-30. PubMed ID: 24974916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
    J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
    Miyagawa-Hayashino A; Haga H; Egawa H; Hayashino Y; Sakurai T; Minamiguchi S; Tanaka K; Manabe T
    Transplantation; 2004 Jul; 78(1):128-35. PubMed ID: 15257051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
    Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
    Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
    Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic management of post-liver transplant billiary complications: A prospective study from tertiary centre in India.
    Ranjan P; Bansal RK; Mehta N; Lalwani S; Kumaran V; Sachdeva MK; Kumar M; Nundy S
    Indian J Gastroenterol; 2016 Jan; 35(1):48-54. PubMed ID: 26873087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.